Evidence map›Paper›PMID 33668357›Full record

ReviewBiomolecules2021

Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma.

Alejandro Martínez-Águila, Alba Martín-Gil, Carlos Carpena-Torres, Cristina Pastrana, Gonzalo Carracedo

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Circadian IOP Rhythm in Rats Is Driven by Neural Signals From the Brain.Investigative ophthalmology & visual science · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Natural Compounds for Preventing Age-Related Diseases and Cancers.International journal of molecular sciences · 2024
    Review
  14. Review
  15. Polymorphism of theAnimals : an open access journal from MDPI · 2023
    Article
  16. Article
  17. Zeitschrift fur praktische Augenheilkunde & augenarztliche Fortbildung : ZPA · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alejandro Martínez-ÁguilaOcupharm Research Group, Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, 28037 Madrid, Spain.ORCID 0000-0001-8228-8180
Alba Martín-GilOcupharm Research Group, Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, 28037 Madrid, Spain.ORCID 0000-0001-8641-2169
Carlos Carpena-TorresOcupharm Research Group, Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, 28037 Madrid, Spain.ORCID 0000-0001-9077-3557
Cristina PastranaOcupharm Research Group, Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, 28037 Madrid, Spain.
Gonzalo CarracedoOcupharm Research Group, Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, 28037 Madrid, Spain.ORCID 0000-0003-0054-1731
Universidad Complutense de Madrid · ES

Funding

Ministerio de Economía y Competitividad SAF2016-77084-R
6 · The paper itself

Abstract

Circadian rhythm and the molecules involved in it, such as melanopsin and melatonin, play an important role in the eye to regulate the homeostasis and even to treat some ocular conditions. As a result, many ocular pathologies like dry eye, corneal wound healing, cataracts, myopia, retinal diseases, and glaucoma are affected by this cycle. This review will summarize the current scientific literature about the influence of circadian patterns on the eye, focusing on its relationship with increased intraocular pressure (IOP) fluctuations and glaucoma. Regarding treatments, two ways should be studied: the first one, to analyze if some treatments could improve their effect on the ocular disease when their posology is established in function of circadian patterns, and the second one, to evaluate new drugs to treat eye pathologies related to the circadian rhythm, as it has been stated with melatonin or its analogs, that not only could be used as the main treatment but as coadjutant, improving the circadian pattern or its antioxidant and antiangiogenic properties.

Indexed as

AnimalsCircadian RhythmDry Eye SyndromesGlaucomaHumansIntraocular PressureMelatoninMyopiaMelatonincircadian rhythmdry eyeglaucomamelanopsinmelatoninmyopiaocular diseases

Identifiers

PMID33668357
PMCPMC7996162
OpenAlexW3133158263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.